FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Hetero Labs Limited Unit V Valganciclovir Tablets Recall

Valganciclovir Tablets, USP, 450 mg, 60-count bottle, Rx Only, Manufactured for Cambe…

Hetero Labs Limited Unit V

Risk level
Class II
Reported by FDA
Mar 21, 2018
Recall ID
D-0601-2018
Check your lot numberHow we source this data

Summary

Hetero Labs Limited Unit V recalled Valganciclovir Tablets starting Feb 13, 2018. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0601-2018 on Mar 21, 2018. Reason: Temperature Abuse: Valganciclovir Tablets USP 450 mg and Valacyclovir Tablets USP 1 gram were exposed to higher temperature at airport or cargo and in the same consignment of Famciclovir complaint batch (D-0415-2018). Status: Terminated.

Why it was recalled

Temperature Abuse: Valganciclovir Tablets USP 450 mg and Valacyclovir Tablets USP 1 gram were exposed to higher temperature at airport or cargo and in the same consignment of Famciclovir complaint batch (D-0415-2018).

Product description

Valganciclovir Tablets, USP, 450 mg, 60-count bottle, Rx Only, Manufactured for Camber Pharmaceuticals, Inc. Piscataway, NJ 08854, By: Hetero Hetero Labs Limit Unit V Pollypally Jadcherla Mahaboob Nagar - 509 301 India. NDC # 31722-832-60

Lot numbers, UPCs & expiration codes

Lot #s VGC17040 & VGC17041, EXP 07/2019

Where it was sold

NJ and then distributed Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0601-2018
Classification
Class II
Status
Terminated
Recall initiated
Feb 13, 2018
FDA report date
Mar 21, 2018
Quantity
1764 60-count bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Hetero Labs Limited Unit V

Original FDA data

Every field from FDA enforcement report D-0601-2018, exactly as published.

Show all FDA fields
City
Jadcherla Mandal, Mahaboob Nagar
Status
Terminated
Country
India
Event ID
79142
Address
Unit V (SEZ Unit I in APIIC SEZ)
Address (line 2)
Surv. No. 439-441, 458, Polepally Vill.
Code information
Lot #s VGC17040 & VGC17041, EXP 07/2019
Report date
Mar 21, 2018
Product type
Drugs
Recall number
D-0601-2018
Classification
Class II
Recalling firm
Hetero Labs Limited Unit V
Product quantity
1764 60-count bottles
Termination date
Feb 18, 2021
Reason for recall
Temperature Abuse: Valganciclovir Tablets USP 450 mg and Valacyclovir Tablets USP 1 gram were exposed to higher temperature at airport or cargo and in the same consignment of Famciclovir complaint batch (D-0415-2018).
Voluntary / mandated
Voluntary: Firm initiated
Product description
Valganciclovir Tablets, USP, 450 mg, 60-count bottle, Rx Only, Manufactured for Camber Pharmaceuticals, Inc. Piscataway, NJ 08854, By: Hetero Hetero Labs Limit Unit V Pollypally Jadcherla Mahaboob Nagar - 509 301 India. NDC # 31722-832-60
Distribution pattern
NJ and then distributed Nationwide in the USA
Recall initiation date
Feb 13, 2018
Initial firm notification
Letter
Center classification date
Mar 16, 2018

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0601-2018, published Mar 21, 2018. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls